Medical News

RSS

High blood sugar in mother during pregnancy leads to reduced insulin sensitivity in children

Children of mothers whose blood glucose (sugar) was high during pregnancy are more likely to have low insulin sensitivity—a risk factor for type 2 diabetes—even after taking into consideration the children's body weight, a new study shows. The results will be presented Tuesday at The Endocrine Society's 92nd Annual Meeting in San Diego.

23 Jun 2010

Student receives two-year $46,000 fellowship to research on a parasite that causes Chagas' disease

Michelle Oppenheimer of Charlotte, N.C., a Ph.D. student in biochemistry in the College of Agriculture and Life Sciences at Virginia Tech, has received a two-year $46,000 fellowship from the American Heart Association to advance her research on a parasite that causes Chagas' disease, which can lead to swelling and inflammation of the heart.

23 Jun 2010

Insurers will receive Presidential warning while administration to release regulations to protect consumers

President Obama will warn health insurance executives at a White House meeting Tuesday against trying to increase premium rates before the new law takes effect, The New York Times reports. "The White House is concerned that health insurers will blame the new law for increases in premiums that are intended to maximize profits rather than covering claims."

23 Jun 2010

Resveratrol found in red wine neutralizes toxicity of proteins related to Alzheimer's disease: Research

An organic compound found in red wine - resveratrol - has the ability to neutralize the toxic effects of proteins linked to Alzheimer's disease, according to research led by Rensselaer Professor Peter M. Tessier. The findings, published in the May 28 edition of the Journal of Biological Chemistry, are a step toward understanding the large-scale death of brain cells seen in certain neurodegenerative diseases.

23 Jun 2010

Corgenix receives new European patent for AtherOx technology

Corgenix Medical Corporation, a worldwide developer and marketer of diagnostic test kits, announced today the issuance of one new European patent for the company's AtherOx® (oxLDL/B2GPI) technology and the publication of an important clinical trial studying oxLDL/B2GPI levels in patients with acute coronary syndrome (ACS).

23 Jun 2010

UAB receives $1.47M NHLBI grant to study red blood cell lesion

Researchers in the University of Alabama at Birmingham (UAB) departments of Pathology, Microbiology and Surgery have received a $1.47 million grant from the National Heart, Lung, and Blood Institute (NHLBI) to study so-called red blood cell lesion, a term given to the potentially harmful changes in red blood cells that have been stored for longer times after collection.

23 Jun 2010

UCL scientists explain Parkinson's disease patients' ICBs

Scientists at UCL have explained Parkinson's patients' risky behaviour, a rare side effect of standard treatments for the disease. The finding has implications for future medication of patients.

23 Jun 2010

ATP-driven bioluminescence predicts children at high risk for tooth decay: OHSU study

Researchers at the Oregon Health & Science University School of Dentistry have determined that ATP-driven (adenosine triphosphate-driven) bioluminescence - a way of measuring visible light generated from ATP contained in bacteria - is an innovative tool for rapidly assessing in children at the chair-side the number of oral bacteria and amount of plaque that can ultimately lead to tooth decay.

23 Jun 2010

Prosensa, GSK initiate additional programs for DMD

Prosensa, the Dutch biopharmaceutical company focusing on RNA modulating therapeutics, announces the initiation of two further programmes under its existing alliance with GSK covering novel RNA-based treatments for Duchenne Muscular Dystrophy (DMD). The initiation of these additional programs under the terms of the existing alliance agreement is a validation of both the potential of Prosensa's "exon skipping" platform and the ongoing relationship.

23 Jun 2010

Regular and long enough intake of EGb 761 protects against Alzheimer's disease: GuidAge study

For the very first time, a medicine has been shown to protect against the development of Alzheimer's disease. French scientists were able to demonstrate that taking 240 mg of Ginkgo extract EGb 761 per day regularly over a period of at least 4 years can cut the risk of developing Alzheimer's disease by nearly 50%.

23 Jun 2010

EdgeBio introduces Science as a Service concept built on top of CLC Genomics Server

Today at the inaugural Beyond Sequencing conference in San Francisco, EdgeBio introduced their Science as a Service concept built on top of CLC bio's enterprise platform, CLC Genomics Server. EdgeBio's end-to-end service concept leads each scientist and project from conception and project design through bioinformatics and analysis.

23 Jun 2010

Public health program to migrant preschool children helps reduce risk of obesity: Study

Migrant children are at increased risk of obesity, but a new study shows that a program teaching multiple lifestyle changes to predominantly migrant preschoolers and their parents helps the children reduce body fat and improve fitness. The results will be presented Monday at The Endocrine Society's 92nd Annual Meeting in San Diego.

23 Jun 2010

PBMs: Post Office plan to end Saturday shipments could boost drug prices

Pharmacy-benefits management companies, including CVS Caremark and Medco, are worried that a U.S. Postal Service plan to end Saturday delivery could raise mail-order drug prices, Bloomberg Businessweek reports. "The pharmacy-benefits management companies, which shipped more than 150 million drug orders last year, joined retailer Crate and Barrel and publishers of small newspapers to challenge the Postal Service and its plan to cut service to save about $3 billion a year." The Post Office is trying to combat a projected $7 billion deficit this year (Keane, 6/21).

23 Jun 2010

Nymox reports positive new results from NX02-0014 follow-up study of NX-1207 for BPH

Nymox Pharmaceutical Corporation is pleased to report positive new results from the 48-60 month follow-up study of patients treated with NX-1207 in Study NX02-0014. The initial study, completed in the U.S. in 2006, reached statistical significance in Intent-to-Treat Primary Efficacy outcomes at 90 days post-treatment with NX-1207 2.5 mg.

23 Jun 2010

Johns Hopkins School of Medicine develops RAALI for healthcare providers

The Johns Hopkins School of Medicine, the nation's leading medical school recipient of research funds from the National Institutes of Health and a recognized center for "Best Practices" by the Accreditation Council for Continuing Medical Education, discussed the development of a unique medical education initiative - the Rheumatoid Arthritis Action Lab Initiative - to give healthcare providers connectivity to much-needed information on rheumatoid arthritis.

23 Jun 2010

Going barefoot in home may contribute to falls among elderly: Study

As summer rolls around, elderly people may want to think twice about taking their shoes off when they get home. Going barefoot in the home, or wearing slippers or socks with no shoes, may contribute to falls among the elderly, according to a new study from the Institute for Aging Research of Hebrew SeniorLife.

23 Jun 2010

World Bank provides over $63M for multi-country lab network in East Africa region

East African Business Week/allAfrica.com reports on the recent decision by the World Bank to back the creation of "a unique regional network of 25 public health laboratories" in Kenya, Tanzania, Uganda and Rwanda with $63.66 million in support.

23 Jun 2010

GSK, Medivir sign exclusive agreement for commercialization of Xerclear

GlaxoSmithKline and Medivir today announced an exclusive agreement for the commercialization of cold sore treatment, Xerclear (acyclovir and hydrocortisone) for non-prescription use (OTC) in key global markets. Xerclear is the first and only topical herpes labialis (cold sores) treatment clinically proven to help prevent cold sore lesions appearing.

23 Jun 2010

Scientists discover weakness of human louse

Scientists have discovered the human louse's Achilles' heel which could lead to new treatments to rid us of body and head lice infestations.

23 Jun 2010

Scientists apply fuzzy logic modeling to predict aging progresses in cells, organisms

The process of aging disturbs a broad range of cellular mechanisms in a complex fashion and is not well understood. Computer models using fuzzy logic might help to unravel these complexities and predict how aging progresses in cells and organisms, according to a study from Drexel University in Philadelphia and Children's Hospital Boston.

23 Jun 2010

Medical News

High blood sugar in mother during pregnancy leads to reduced insulin sensitivity in children

Student receives two-year $46,000 fellowship to research on a parasite that causes Chagas' disease

Insurers will receive Presidential warning while administration to release regulations to protect consumers

Resveratrol found in red wine neutralizes toxicity of proteins related to Alzheimer's disease: Research

Corgenix receives new European patent for AtherOx technology

UAB receives $1.47M NHLBI grant to study red blood cell lesion

UCL scientists explain Parkinson's disease patients' ICBs

ATP-driven bioluminescence predicts children at high risk for tooth decay: OHSU study

Prosensa, GSK initiate additional programs for DMD

Regular and long enough intake of EGb 761 protects against Alzheimer's disease: GuidAge study

EdgeBio introduces Science as a Service concept built on top of CLC Genomics Server

Public health program to migrant preschool children helps reduce risk of obesity: Study

PBMs: Post Office plan to end Saturday shipments could boost drug prices

Nymox reports positive new results from NX02-0014 follow-up study of NX-1207 for BPH

Johns Hopkins School of Medicine develops RAALI for healthcare providers

Going barefoot in home may contribute to falls among elderly: Study

World Bank provides over $63M for multi-country lab network in East Africa region

GSK, Medivir sign exclusive agreement for commercialization of Xerclear

Scientists discover weakness of human louse

Scientists apply fuzzy logic modeling to predict aging progresses in cells, organisms

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

From Puberty to Menopause: Clue’s CEO, Audrey Tsang on the Power of Femtech

Latest News